NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/17/2026
Back to search
Official data from USPTO
IVRAFERAV
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
03/17/2026
Trademark type
Word
Nice classes
5
Filing date
10/19/2023
Registration date
03/17/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/17/2026
Last transaction
03/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/01/2025
First use in commerce
08/01/2025
Drawing code
4
Owner type
99
Owner location
Longhua Dist.,Shenzhen, CN
Examiner
GARTNER, JOHN M
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
IMMVIRA CO., LIMITED
Representatives
Angel Roman Campos MUNCY, GEISSLER, OLDS & LOWE, PC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Antiseptics; Biological preparations for the treatment of cancer; Human vaccine preparations; Immunostimulants; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Oral vaccine preparations; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparationsantivirals; Vaccine preparations; Vaccines; Viral vaccines
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/17/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/24/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/24/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/24/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/20/2026
IUAF
USE AMENDMENT FILED
08/15/2025
EISU
TEAS STATEMENT OF USE RECEIVED
08/15/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/15/2025
EX1G
SOU EXTENSION 1 GRANTED
02/15/2025
EXT1
SOU EXTENSION 1 FILED
02/14/2025
EEXT
SOU TEAS EXTENSION RECEIVED
02/14/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/03/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/09/2024
PUBO
PUBLISHED FOR OPPOSITION
07/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/19/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/04/2024
DOCK
ASSIGNED TO EXAMINER
06/04/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/07/2024
NWAP
NEW APPLICATION ENTERED
10/19/2023
Continuous trademark protection
Get notified about every new filing that threatens IVRAFERAV or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.